Literature DB >> 10585445

Transcription factor YY1 is a vaccinia virus late promoter activator.

S S Broyles1, X Liu, M Zhu, M Kremer.   

Abstract

Vaccinia virus has a DNA genome, yet replicates in the cytoplasmic compartment of the cell. We previously described the identification of a cellular protein having high affinity for vaccinia virus late promoter DNA. Sequence substitutions in the vaccinia I1L promoter were used to define a 5-nucleotide block at the transcription initiation site as essential for interaction with the protein. Within this sequence is the recognition motif for the nuclear transcription factor YY1. This factor regulates a multitude of cellular promoters, as an activator of transcription, as a repressor, or as an initiator element-binding protein. Antibodies directed against YY1 were used to show that YY1 copurified with the vaccinia late promoter-binding protein and was present in late promoter-protein complexes in gel supershift assays. Bacterially expressed YY1 also bound specifically to late promoter DNA. A dinucleotide replacement within the YY1 recognition motif directly adjacent to the transcription start site severely reduced the affinity of YY1 for the I1L promoter in vitro and impaired I1L promoter-dependent transcription in vivo. The intracellular localization of YY1 was shown by immunofluorescence microscopy to shift from primarily nuclear to the cytoplasm after vaccinia infection. These results indicate that YY1 has a positive role in the regulation of vaccinia virus late gene transcription and suggest that poxviruses have adapted cellular initiator elements as a means of regulating viral gene expression. This is the first identifiable cellular protein implicated in poxvirus transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585445     DOI: 10.1074/jbc.274.50.35662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Structure of African swine fever virus late promoters: requirement of a TATA sequence at the initiation region.

Authors:  R García-Escudero; E Viñuela
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology.

Authors:  Patrícia N G Silva; Jamária A P Soares; Bruno S A F Brasil; Sarah V Nogueira; Anderson A Andrade; José C de Magalhães; Marisa B Bonjardim; Paulo C P Ferreira; Erna G Kroon; Oscar Bruna-Romero; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

3.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes.

Authors:  Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells.

Authors:  Jye-Chian Hsiao; Chien-Chiang Chao; Ming-Jer Young; Yu-Tai Chang; Er-Chieh Cho; Wen Chang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles.

Authors:  Ana Paula V Castro; Técia M U Carvalho; Nissin Moussatché; Clarissa R A Damaso
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.

Authors:  Nouhou Ibrahim; April Wicklund; Augusta Jamin; Matthew S Wiebe
Journal:  Virology       Date:  2013-07-24       Impact factor: 3.616

9.  Antiviral activity of distamycin A against vaccinia virus is the result of inhibition of postreplicative mRNA synthesis.

Authors:  Steven S Broyles; Marcia Kremer; Bruce A Knutson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Heat shock protein and heat shock factor 1 expression and localization in vaccinia virus infected human monocyte derived macrophages.

Authors:  Aleksandra Kowalczyk; Krzysztof Guzik; Kinga Slezak; Jakub Dziedzic; Hanna Rokita
Journal:  J Inflamm (Lond)       Date:  2005-10-24       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.